Nifty
Sensex
:
:
11807.10
40137.59
39.35 (0.33%)
-7.91 (-0.02%)

Pharmaceuticals & Drugs

Rating :
79/99  (View)

BSE: 539997 | NSE: Not Listed

59.00
-0.80 (-1.34%)
21-Oct-2020 | 4:01PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  59.00
  •  59.00
  •  59.00
  •  59.80
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  3000
  •  1.77
  •  63.80
  •  21.30

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 61.22
  • 7.36
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 88.56
  • N/A
  • 1.68

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 51.52%
  • 19.47%
  • 25.20%
  • FII
  • DII
  • Others
  • 0%
  • 0.00%
  • 3.81%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 12.21

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 1.66

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 5.88

Quarterly Results

Standalone Figures in Rs. Crores

Description
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Dec 19
Dec 18
Var%
Sep 19
Sep 18
Var%
Net Sales
0
0
0
0
0
0
0
0
0
0
0
0
Expenses
0
0
0
0
0
0
0
0
0
0
0
0
EBITDA
0
0
0
0
0
0
0
0
0
0
0
0
EBIDTM
0%
0%
0%
0%
0%
0%
0%
0%
Other Income
0
0
0
0
0
0
0
0
0
0
0
0
Interest
0
0
0
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
0
0
PBT
0
0
0
0
0
0
0
0
0
0
0
0
Tax
0
0
0
0
0
0
0
0
0
0
0
0
PAT
0
0
0
0
0
0
0
0
0
0
0
0
PATM
0%
0%
0%
0%
0%
0%
0%
0%
EPS
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Net Sales
-
166
137
98
74
52
60
Net Sales Growth
-
21%
40%
33%
42%
-12%
 
Cost Of Goods Sold
-
119
102
71
57
39
46
Gross Profit
-
47
36
27
17
14
13
GP Margin
-
28%
26%
27%
23%
26%
23%
Total Expenditure
-
151
126
89
69
49
56
Power & Fuel Cost
-
4
3
3
2
2
0
% Of Sales
-
2%
2%
3%
3%
3%
0%
Employee Cost
-
8
5
4
2
2
2
% Of Sales
-
5%
4%
4%
3%
3%
3%
Manufacturing Exp.
-
3
5
3
1
1
0
% Of Sales
-
2%
4%
3%
2%
2%
0%
General & Admin Exp.
-
6
3
3
3
1
8
% Of Sales
-
4%
2%
3%
4%
3%
14%
Selling & Distn. Exp.
-
11
8
5
3
4
0
% Of Sales
-
6%
6%
5%
4%
8%
0%
Miscellaneous Exp.
-
0
0
1
0
0
0
% Of Sales
-
0%
0%
1%
1%
1%
0%
EBITDA
-
16
12
9
5
3
4
EBITDA Margin
-
9%
8%
9%
7%
6%
6%
Other Income
-
1
1
1
0
0
0
Interest
-
2
2
2
1
1
1
Depreciation
-
3
3
3
2
1
1
PBT
-
11
7
6
2
1
2
Tax
-
3
3
2
1
1
1
Tax Rate
-
31%
39%
42%
48%
41%
46%
PAT
-
8
5
3
2
1
1
PAT before Minority Interest
-
8
4
3
1
1
1
Minority Interest
-
0
0
0
0
0
0
PAT Margin
-
5%
3%
3%
2%
2%
2%
PAT Growth
-
67%
35%
117%
70%
-5%
 
EPS
-
7.27
4.37
3.24
1.49
0.88
0.92

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Shareholder's Funds
37
30
26
21
19
18
Share Capital
10
10
5
5
4
4
Total Reserves
27
19
20
17
15
13
Non-Current Liabilities
8
5
4
3
1
2
Secured Loans
7
3
3
2
0
1
Unsecured Loans
1
2
1
0
0
1
Long Term Provisions
1
1
1
0
0
0
Current Liabilities
61
62
42
27
17
15
Trade Payables
17
22
13
10
4
7
Other Current Liabilities
22
16
11
6
6
4
Short Term Borrowings
19
21
15
10
7
4
Short Term Provisions
3
3
2
1
1
0
Total Liabilities
105
96
71
51
37
35
Net Block
29
20
17
13
13
13
Gross Block
48
36
30
23
23
21
Accumulated Depreciation
19
15
13
10
10
9
Non Current Assets
30
21
18
13
13
13
Capital Work in Progress
0
0
0
0
0
0
Non Current Investment
1
1
1
0
0
0
Long Term Loans & Adv.
0
0
0
0
0
0
Other Non Current Assets
0
0
0
0
0
0
Current Assets
75
75
53
38
24
22
Current Investments
4
5
3
2
1
0
Inventories
11
15
14
10
6
7
Sundry Debtors
38
37
23
18
9
7
Cash & Bank
1
2
3
1
1
1
Other Current Assets
20
0
0
0
7
7
Short Term Loans & Adv.
20
16
11
6
7
7
Net Current Assets
15
13
11
12
7
7
Total Assets
105
96
71
51
37
35

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 19
Mar 18
Mar 17
Mar 16
Cash From Operating Activity
14
-1
4
-3
PBT
11
7
6
2
Adjustment
5
4
5
3
Changes in Working Capital
1
-9
-4
-7
Cash after chg. in Working capital
17
2
7
-2
Interest Paid
0
0
0
0
Tax Paid
-3
-3
-2
-1
Other Direct Exp. Paid
0
0
0
0
Extra & Other Items
0
0
0
0
Cash From Investing Activity
-12
-6
-7
-2
Net Fixed Assets
-12
-6
-7
Net Investments
0
-2
-2
Others
0
2
2
Cash from Financing Activity
-2
5
5
6
Net Cash Inflow / Outflow
0
-1
2
0
Opening Cash & Equivalents
2
3
1
1
Closing Cash & Equivalent
1
2
3
1

Financial Ratios

Standalone /

Consolidated
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Book Value (Rs.)
35
28
24
21
21
20
ROA
8%
5%
5%
3%
2%
3%
ROE
23%
17%
14%
7%
4%
5%
ROCE
22%
19%
20%
12%
10%
11%
Fixed Asset Turnover
3.98
4.20
3.76
3.23
2.35
2.79
Receivable days
83
79
75
67
55
41
Inventory Days
29
38
45
41
48
45
Payable days
50
49
46
37
44
54
Cash Conversion Cycle
62
68
75
71
60
32
Total Debt/Equity
0.79
0.92
0.77
0.62
0.43
0.32
Interest Cover
6
4
4
3
2
3

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.